SIRO Clinpharm, an India-based CRO, has relocated its corporate headquarters within Mumbai, India. The move allows SIRO to consolidate its position in the Indian healthcare development space.

"SIRO has a successful history in Mumbai, which has allowed it to expand regionally as well as globally. This facility will allow SIRO to house all of its functions under one roof and help us to take forward our philosophy of One Data, One Team and integrated teams, where all functions, in Mumbai and elsewhere, will work like one integrated virtual team. This will help us improve our focus on serving our clients with better efficiencies and cross-functional benefits," said Dr. Vatsal Shah, global head, medical writing, biometrics and pharmacovigilance.

Partha Chatterjee, head of clinical research and clinical trial supplies, said, "SIRO Clinpharm continues to grow and this move gives us flexibility to scale up with the increasing client needs."